|
|
Other links at Articles > Allergy and Clinical Immunology |
| 2. |
Omalizumab Not Cost Effective for Severe Asthma
|
|
|
Omalizumab is not a cost-effective treatment for most patients with severe asthma, according to an analysis presented in the November Journal of Allergy and Clinical Immunology. Reuters Health Information
|
| 4. |
Filaggrin Gene Mutations Predict Course of Eczema
|
|
|
Common mutations in the filaggrin gene (FLG) confer risk of eczema and are a strong determinant of disease duration with the development of asthma, according to a study conducted in the United Kingdom. Reuters Health Information
|
|
|